Pre-Exposure Prophylaxis (PrEP) for Adolescents and Young Adults at Risk for HIV Infection: Is an Ounce of Prevention Worth a Pound of Cure?
Clin. Infect. Dis., Dec (2012)
Cardiac Biomarkers in HIV-Exposed Uninfected Children: The Pediatric HIV/AIDS Cohort Study (PHACS).
AIDS., Dec (2012)
Sexual Risk Behavior Among Youth With Perinatal HIV Infection in the United States: Predictors and Implications for Intervention Development.
Clin. Infect. Dis., Nov (2012)
Bone mineral density in children and adolescents with perinatal HIV infection.
AIDS., Oct (2012)
Methicillin-Resistant Staphylococcus aureus Infections in Human Immunodeficiency Virus-Infected Children and Adolescents.
AIDS Res Treat., 2012:627974 (2012)
Antiretroviral Treatment Strategies in Highly Treatment Experienced Perinatally HIV-infected Youth.
Pediatr. Infect. Dis. J., Dec;31(12):1279-1283 (2012)
Immunogenicity and safety of 1 vs 2 doses of quadrivalent meningococcal conjugate vaccine in youth infected with human immunodeficiency virus.
J. Pediatr., Oct;161(4):676-81.e2 (2012)
Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1-infected children, adolescents, and young adults.
J. Infect. Dis., Aug;206(3):421-30 (2012)
Hearing loss in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents.
Pediatr. Infect. Dis. J., Aug;31(8):835-41 (2012)
Predictors of highly active antiretroviral therapy utilization for behaviorally HIV-1-infected youth: impact of adult versus pediatric clinical care site.
J Adolesc Health., May;50(5):471-7 (2012)
A trigger-based design for evaluating the safety of in utero antiretroviral exposure in uninfected children of human immunodeficiency virus-infected mothers.
Am. J. Epidemiol., May;175(9):950-61 (2012)
Fracture risk by HIV infection status in perinatally HIV-exposed children.
AIDS Res. Hum. Retroviruses., Mar;28(3):247-50 (2012)
Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants.
AIDS., Jun;26(9):1151-9 (2012)
Evaluation of viral load thresholds for predicting new World Health Organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy.
J. Acquir. Immune Defic. Syndr., Jun;60(2):214-8 (2012)
Language impairment in children perinatally infected with HIV compared to children who were HIV-exposed and uninfected.
J Dev Behav Pediatr., Feb;33(2):112-23 (2012)
Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected children.
HIV Med., May;13(5):264-75 (2012)
A mechanistic role for type III IFN-Î»1 in asthma exacerbations mediated by human rhinoviruses.
Am. J. Respir. Crit. Care Med., Mar;185(5):508-16 (2012)
Increased risk of asthma and atopic dermatitis in perinatally HIV-infected children and adolescents.
Clin. Immunol., Feb;142(2):201-8 (2012)
Cervical pap screening cytological abnormalities among HIV-infected adolescents in the LEGACY cohort.
J Pediatr Adolesc Gynecol., Feb;25(1):27-34 (2012)
Body fat distribution in perinatally HIV-infected and HIV-exposed but uninfected children in the era of highly active antiretroviral therapy: outcomes from the Pediatric HIV/AIDS Cohort Study.
Am. J. Clin. Nutr., Dec;94(6):1485-95 (2011)